Dayspring Pharma Announces Phase II Trial of CG2001 Foam Met Primary Endpoint in Chinese Adult Men with AGA
BEIJING, April 22, 2026 /PRNewswire/ -- Dayspring Pharma today announced top-line data from its Phase II clinical trial of CG2001 foam in male patients with androgenetic alopecia (AGA). The trial met its primary endpoint and demonstrated...
NOVI Health's Hybrid Care Model Closes Gap Between Clinical Trials and Real-World GLP-1 Outcomes
An estimated ~14.7% weight loss at 18 months was achieved in one of the first studies evaluating integrated GLP-1 therapies and digital coaching in a multi-ethnic Asian population (n=708). This matched gold-standard clinical trial results, with...
AIA Singapore reimagines sustainability through the eyes of children in new short film series
This four-part series explores a fresh perspective on sustainability, showing how care for the environment and the world is an intuitive, lifelong value, instilled at a young age. SINGAPORE, April 22, 2026 /PRNewswire/ -- AIA Singapore today...
TotalEnergies ENEOS signs 15-year PPA with Thailand's Jintana Intertrade
NAKHON RATCHASIMA, Thailand, April 22, 2026 /PRNewswire/ -- TotalEnergies ENEOS and Jintana Intertrade Co., Ltd. (Jintana), an established Thai garment manufacturer, signed a 15-year Power Purchase Agreement (PPA) to develop a 650 kilowatt-peak...
"Picturesque Zhejiang" Promotion Event, Themed "Travel East: Experience the Best," Opens a New Chapter in Zhejiang-Australia Tourism Cooperation
SYDNEY, April 21, 2026 /PRNewswire/ -- As 2026 marks the start of the second decade of the China-Australia Comprehensive Strategic Partnership, exchanges and collaboration across sectors continue to expand. On the afternoon of April 17, the "Travel...
"Building Community, Building Tung Chung" Programme Reaches 200,000 Beneficiaries in Six Years
Empowering Residents and Strengthening Community Solidarity HONG KONG, April 21, 2026 /PRNewswire/ -- Supported by The Swire Group Charitable Trust (Swire Trust) and coordinated by The Hong Kong Council of Social Service (HKCSS), "Building...
Ractigen Therapeutics Presents Positive Phase I Data for RAG-17 in SOD1-ALS at the 2026 AAN Annual Meeting, Demonstrating 81% Reduction in Neurofilament Light Chain
— Single intrathecal dose of SCAD-siRNA therapeutic RAG-17 yields favorable safety profile and profound, durable biomarker reductions — — Preliminary data from 180 mg cohort shows trends of clinical stabilization (ALSFRS-R) — — Phase II trial is now...
International Jewellery Kobe (IJK) 2026--Western Japan's Largest Jewellery Trade Show Marks Its 30th Edition in May with 480 exhibitors
TOKYO, April 22, 2026 /PRNewswire/ -- International Jewellery Kobe (IJK) will be held May 14–16, 2026 at Kobe International Exhibition Hall, returning for its landmark 30th edition as a business-first marketplace for the jewellery trade. Recognised...